Carisma Therapeutics (CARM) Q4 2024 Earnings

7NovConfirmed
Q1 1
Q2 2024
Q3 2024
Q4 2024
-0.46
-0.36
-0.25
-0.15

Details

Expected EPS
-0.315
Actual EPS
-0.31
Surprise EPS
0.01
Surprise Percent
+1.59%

Description

Carisma Therapeutics (CARM) has reported earnings of -0.31 per share for Q4 2024.

0 Comments

Share your thoughts